Levy Dan D, Hakura Atsushi, Elespuru Rosalie K, Escobar Patricia A, Kato Masayuki, Lott Jasmin, Moore Martha M, Sugiyama Kei-Ichi
US Food and Drug Administration Center for Food Safety and Applied Nutrition, College Park, MD, USA.
Tsukuba Drug Safety, Eisai Co., Ltd., Tsukuba, Ibaraki, Japan.
Mutat Res Genet Toxicol Environ Mutagen. 2019 Dec;848:403075. doi: 10.1016/j.mrgentox.2019.07.005. Epub 2019 Jul 12.
The bacterial reverse mutation test is a mainstay for evaluation of mutagenicity predicting the carcinogenic potential of a test substance and is recommended by regulatory agencies across the globe. The popularity of the test is due, in part, to the relatively low cost, rapid results and small amount of test material required compared to most other toxicological tests as well as the near universal acceptance of the toxicological significance of a clear positive or negative result. Most laboratories follow the Organization for Economic Cooperation and Development Test Guideline 471 (TG471) or national guidelines based on TG471. Regulatory agencies in most countries are obligated to consider results from tests which meet the recommendations laid out in TG471. Nonetheless, laboratories unfamiliar with the test sometimes have trouble generating reliable, reproducible results. TG471 is a test guideline, not a detailed test protocol. A group of experts from regulatory agencies and laboratories which use the assay has assembled here a set of recommendations which if followed, will allow an inexperienced laboratory to acquire proficiency in assay conduct. These include recommendations for how to create a cell bank for the 5 Salmonella typhimurium/Escherichia coli strains and develop a laboratory protocol to reliably culture each strain to ensure each culture has the characteristics which allow adequate sensitivity for detection of mutagens using the test as described in TG471. By testing compounds on the provided lists of positive and negative test substances, the laboratory will have surmounted many of the problems commonly encountered during routine testing of unknown chemicals and will have gained the experience necessary to prepare the detailed protocol needed for performing the test under Good Laboratory Procedures and the laboratory will have generated the historical positive and negative control databases which are needed for test reports which adhere to TG471.
细菌回复突变试验是评估诱变活性以预测受试物质致癌潜力的主要方法,全球监管机构均推荐使用。该试验之所以受欢迎,部分原因在于与大多数其他毒理学试验相比,其成本相对较低、结果快速且所需试验材料量少,以及明确的阳性或阴性结果在毒理学意义上几乎得到普遍认可。大多数实验室遵循经济合作与发展组织试验指南471(TG471)或基于TG471的国家指南。大多数国家的监管机构有义务考虑符合TG471中列出建议的试验结果。尽管如此,不熟悉该试验的实验室有时在产生可靠、可重复的结果方面存在困难。TG471是一项试验指南,而非详细的试验方案。来自监管机构和使用该试验的实验室的一组专家在此汇编了一套建议,若遵循这些建议,将使缺乏经验的实验室能够熟练进行试验。这些建议包括如何为5种鼠伤寒沙门氏菌/大肠杆菌菌株创建细胞库,以及制定实验室方案以可靠培养每种菌株,确保每种培养物具有能够如TG471中所述对诱变剂检测具有足够敏感性的特性。通过对提供的阳性和阴性试验物质列表中的化合物进行测试,实验室将克服未知化学品常规测试过程中常见的许多问题,并获得按照良好实验室规范进行试验所需详细方案的经验,且实验室将生成遵循TG471的试验报告所需的历史阳性和阴性对照数据库。